ANGELICI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 664
EU - Europa 225
AS - Asia 80
SA - Sud America 10
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 982
Nazione #
US - Stati Uniti d'America 660
UA - Ucraina 67
SE - Svezia 58
IT - Italia 42
CN - Cina 38
IN - India 37
FI - Finlandia 25
GB - Regno Unito 11
AR - Argentina 10
BE - Belgio 6
IE - Irlanda 6
CA - Canada 4
FR - Francia 4
SG - Singapore 4
DE - Germania 3
BG - Bulgaria 1
EE - Estonia 1
EU - Europa 1
PK - Pakistan 1
RO - Romania 1
TG - Togo 1
ZA - Sudafrica 1
Totale 982
Città #
Fairfield 80
Chandler 69
Woodbridge 57
Ann Arbor 38
Ashburn 36
Wilmington 34
Beijing 32
Houston 32
Jacksonville 29
Cambridge 25
Princeton 22
Seattle 22
Plano 21
Millbury 14
Boardman 13
Boston 13
Rome 13
San Paolo di Civitate 12
Lawrence 11
Federal 10
San Diego 10
Andover 6
Brussels 6
Dublin 6
Dearborn 4
Falls Church 4
Norwalk 4
Toronto 4
Cesano Boscone 3
Helsinki 3
Singapore 3
Bühl 2
Des Moines 2
Fremont 2
Marseille 2
Mentana 2
New York 2
Shanghai 2
Washington 2
Arnsberg 1
Buffalo 1
Cormeilles-en-Parisis 1
Hefei 1
Indiana 1
Islamabad 1
Lappeenranta 1
Lomé 1
Los Angeles 1
Milan 1
Muizenberg 1
Potenza 1
Provo 1
Quzhou 1
San Mateo 1
Sofia 1
Southend 1
Tallinn 1
Tivoli 1
Xian 1
Totale 672
Nome #
A Simplified Approach for the Estimation of the Ventilatory Compensation Point 96
Carriage of Pneumocystis carinii in children with chronic lung diseases 86
Structural changes in rat Pneumocystis carinii surface antigens after terbinafine administration in experimental P. Carinii pneumonia 66
Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients 62
The plasminogen system and transforming growth factor-β in subjects with obstructive sleep pnea syndrome: effects of CPAP treatment 62
Cytomegalovirus in bronchoalveolar lavage specimens from patients with AIDS: comparison with antigenaemia and viraemia 60
Employment of terbinafine against Pneumocystis carinii infection in rat models 57
Effect of Pneumocystis carinii(PC) and Cytomegalovirus (CMV) on Plasminogen activator (PA) system in mononuclear phagocytes 55
Detection of the ventilatory compensation point (VCP9) during incremental exercise by the analysis of V'E-HR relationship 48
Diagnosi e valutazione funzionale del paziente con ipertensione polmonare 45
Production of plasminogen activator by alveolar macrophages in experimental pneumocystis pneumonia 39
EFFECT OF TREATMENT ON PEAK OXYGEN UPTAKE DURIING INCREMENTAL EXERCISE IN IPAH 38
Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without P. Jiroveci infection. 34
Changing antigenic pattern of rat Pneumocystis carinii(PC) during treatment with terbinafine in experimental pneumonia 33
Exertional dispnoea in IPAH 33
The Plasminogen System and TGF-b in OSAS subjects: Effects of CPAP treatment 33
Use of non invasive ventilation (NIV) in a general medical ward (GMW) for the treatment of acute hypercapnic respiratory failure (AHRF) in COPD 33
Structural changes in rat P.carinii surface antigens after terbinafine administration 32
Hydroxyurea-induced interstitial pneumonitis: case report and review of the literature 30
Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without Pneumocystis carinii. 29
Plasminogen activator production in a rat model of Pneumocystis carinii pneumonae 25
Totale 996
Categoria #
all - tutte 2.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201948 0 0 0 0 0 0 0 0 0 0 30 18
2019/2020239 38 16 6 20 16 22 21 27 18 38 11 6
2020/202182 12 13 2 9 0 8 2 7 7 16 5 1
2021/2022196 3 14 14 7 24 3 4 26 18 16 16 51
2022/2023243 37 36 28 21 36 35 0 8 28 0 11 3
2023/202463 8 16 6 9 7 4 2 3 0 6 2 0
Totale 996